Needham & Company LLC Reaffirms “Hold” Rating for Definitive Healthcare (NASDAQ:DH)

Definitive Healthcare (NASDAQ:DH)‘s stock had its “hold” rating reissued by stock analysts at Needham & Company LLC in a report issued on Friday,Benzinga reports.

DH has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft cut their price target on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Robert W. Baird cut their target price on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Barclays lowered their price target on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 7th. Stifel Nicolaus cut their price objective on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a research report on Wednesday, July 31st. Finally, BTIG Research initiated coverage on Definitive Healthcare in a research note on Tuesday, September 17th. They set a “buy” rating and a $7.00 target price on the stock. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $5.81.

Definitive Healthcare Stock Performance

NASDAQ DH opened at $4.24 on Friday. The firm has a market cap of $500.02 million, a price-to-earnings ratio of -1.22, a PEG ratio of 6.27 and a beta of 1.33. The company has a 50-day simple moving average of $4.36 and a two-hundred day simple moving average of $5.00. The company has a quick ratio of 2.40, a current ratio of 2.40 and a debt-to-equity ratio of 0.27. Definitive Healthcare has a 12-month low of $3.19 and a 12-month high of $10.62.

Institutional Trading of Definitive Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the business. Norden Group LLC purchased a new stake in shares of Definitive Healthcare during the 1st quarter valued at about $83,000. Oppenheimer Asset Management Inc. boosted its holdings in Definitive Healthcare by 40.5% in the first quarter. Oppenheimer Asset Management Inc. now owns 49,393 shares of the company’s stock worth $399,000 after purchasing an additional 14,229 shares during the last quarter. Swiss National Bank grew its position in Definitive Healthcare by 2.9% in the 1st quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $834,000 after purchasing an additional 2,900 shares during the period. Susquehanna Fundamental Investments LLC bought a new position in shares of Definitive Healthcare during the 1st quarter valued at $120,000. Finally, Vanguard Group Inc. lifted its holdings in shares of Definitive Healthcare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company’s stock valued at $36,600,000 after buying an additional 67,068 shares during the period. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.